{"id":"W2801498218","doi":"10.1038/s41571-018-0030-2","title":"Low-value approvals and high prices might incentivize ineffective drug development","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Medicine; Drug development; Drug; Portfolio; Drug approval; Incentive; Pipeline (software); Clinical trial; Value (mathematics); Actuarial science; Risk analysis (engineering); Intensive care medicine; Public economics; Pharmacology; Finance; Business; Internal medicine; Economics; Microeconomics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002520212,0.0006352863,0.0006368634,0.001161301,0.0002385954,0.001906394,0.0007249512,0.002654172,0.009066987],"category_scores_gemma":[0.004566285,0.0001876401,0.0004611062,0.0007417129,0.001225896,0.001802595,0.001069978,0.002429118,0.001897174],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00112767,"about_ca_system_score_gemma":0.002436445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003348757,"about_ca_topic_score_gemma":0.001021838,"domain_scores_codex":[0.9989536,0.0003104159,0.00007675854,0.0001308252,0.0004226055,0.0001057489],"domain_scores_gemma":[0.9977338,0.001452569,0.0003628316,0.00008218356,0.0002584432,0.0001100427],"domain_codex":null,"domain_gemma":"incentives","domain_candidate":"incentives","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001388462,0.00008659083,0.0004208258,0.005514759,0.0001103093,0.0002164834,0.00005947045,0.0004890687,0.002588692,0.0653443,0.05222771,0.8728031],"study_design_scores_gemma":[0.00006400664,0.0001199052,0.0006656983,0.003555299,0.00009794514,0.0007547247,0.00004874117,0.0001868058,0.001246599,0.02151062,0.9717312,0.00001831248],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002084649,0.9427814,0.004489879,0.01836975,0.002391179,0.00004769361,0.0001082899,0.0001222649,0.0296049],"genre_scores_gemma":[0.05450494,0.8972702,0.006381332,0.02020131,0.002920538,0.0001164235,0.0002068595,0.0000502051,0.01834819],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9974798,"threshold_uncertainty_score":0.03033215,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0935634486123407,"score_gpt":0.4775639335498192,"score_spread":0.3840004849374785,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}